A Study of Participants Ages 21-65 Diagnosed With Dyspareunia and the Effects of Low Intensity Shockwave Treatment

Description

Dyspareunia is defined as a complaint of persistent or recurring pain or discomfort associated with attempted or complete vaginal penetration e purpose of this study is to determine the effectiveness of low intensity shockwave treatment for patients with dyspareunia and their ability to tolerate sexual activity, (i.e., penetration of vagina, self or partnered pleasure). Participants will: * Be given a preliminary physical therapy examination and evaluation. * Be asked to attend weekly low intensity shockwave treatment visits. * Be asked to complete 3 Month follow up questionnaires

Conditions

Female Dyspareunia

Study Overview

Study Details

Study overview

Dyspareunia is defined as a complaint of persistent or recurring pain or discomfort associated with attempted or complete vaginal penetration e purpose of this study is to determine the effectiveness of low intensity shockwave treatment for patients with dyspareunia and their ability to tolerate sexual activity, (i.e., penetration of vagina, self or partnered pleasure). Participants will: * Be given a preliminary physical therapy examination and evaluation. * Be asked to attend weekly low intensity shockwave treatment visits. * Be asked to complete 3 Month follow up questionnaires

Randomized Controlled Trial for Use of Low Intensity Shockwave for Patients With Dyspareunia

A Study of Participants Ages 21-65 Diagnosed With Dyspareunia and the Effects of Low Intensity Shockwave Treatment

Condition
Female Dyspareunia
Intervention / Treatment

-

Contacts and Locations

Wauwatosa

New You Health and Wellness, Wauwatosa, Wisconsin, United States, 53226

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Primary diagnosis of dyspareunia (pain with intercourse and/or vaginal penetration)
  • * Cisgender female or have natal vaginal tissu
  • * Has not started hormonal therapy within the past 2 weeks
  • * Has not received pelvic floor physical therapy within the past 2 weeks
  • * Is able to electronically access informed consent and outcomes measures forms
  • * Have a diagnosis of lichen sclerosis
  • * Have an active infection (e.g. herpes)
  • * Are earlier than 12 weeks post-surgery
  • * Are earlier than 6 weeks postpartum
  • * Have a history of gynecological cancer
  • * Have a history of pelvic radiation
  • * Are actively undergoing cancer treatments
  • * Are currently pregnant
  • * Currently using lidocaine or cortisone

Ages Eligible for Study

21 Years to 65 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

SoftWave Tissue Regeneration Technologies,

Stacey Roberts, PRINCIPAL_INVESTIGATOR,

Study Record Dates

2024-04-30